Skip to content

Evaluation of HE4 in ovarian cancer

Evaluation of HE4 in ovarian cancer - Evaluation of HE4 in ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037812
Enrollment
59
Registered
2019-08-27
Start date
2018-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

None listed

Sponsors

Nihon University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Gynecological surgery cases (ovarian cancer cases, gynecological benign disease cases)

Exclusion criteria

Exclusion criteria: Gynecologic malignant tumor cases other than ovarian cancer

Design outcomes

Primary

MeasureTime frame
ROMA (Risk of Malignancy Algorithm)

Countries

Japan

Contacts

Public ContactTakahiro Nakajima

Nihon University Hospital Department of Obstetrics and Gynecology

nakajima.takahiro@nihon-u.ac.jp03-3293-1711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026